Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Mycoplasma pneumoniae infection in patients with Kawasaki disease

  • Lee, Mi-Na (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Cha, Jie-Hae (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Ahn, Hye-Mi (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Yoo, Jeong-Hyun (Department of Radiology, Ewha Womans University, School of Medicine) ;
  • Kim, Hae-Soon (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Sohn, Se-Jung (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Hong, Young-Mi (Department of Pediatrics, Ewha Womans University, School of Medicine)
  • Received : 2010.02.14
  • Accepted : 2011.03.07
  • Published : 2011.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Kawasaki disease (KD) is the main cause of acquired heart disease in children. In addition to cardiovascular involvement, many complications have been recognized in KD. However, respiratory complications have been rarely reported. We investigated the differences in clinical characteristics, laboratory findings, radiography findings, and echocardiography findings of Mycoplasma pneumoniae infection and other types of pneumonia in KD patients. Methods: Among 358 patients with KD, 54 developed concurrent pneumonia. Among the 54 patients, 12 (22.2%) with high titers of anti-M. pneumoniae antibody (AMA) (>1:640) were grouped in the M. pneumoniae group and 42 were included in the control group. Serum AMA was measured in each patient. Clinical laboratory findings and total duration of fever were analyzed. Results: The duration of fever, serum hemoglobin, white blood cell count, platelet count, erythrocyte sedimentation rate, C-reactive protein level, albumin level, and the incidence of coronary arterial lesions showed no statistical difference in the 2 groups. Neutrophil count was significantly higher in the M. pneumoniae group than in the control group. Among various radiography findings observed in pneumonia, consolidation and pleural effusion were more frequent in the M. pneumoniae group than in the control group. On the other hand, parahilar peribronchial opacification, diffuse interstitial lesion, and normal findings prevailed in the control group. Conclusion: KD patients can have concurrent infections, especially pulmonary symptoms. The cause of KD is likely to be associated with M. pneumoniae infection. Thus, immediate treatment of M. pneumoniae infection in KD patients is very important.

Keywords

References

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
  2. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130:599-607.
  3. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymphnode syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
  4. Fulton DR, Newberger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000;2:324-9. https://doi.org/10.1007/s11926-000-0070-2
  5. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Longterm consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. https://doi.org/10.1161/01.CIR.94.6.1379
  6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. https://doi.org/10.1161/01.CIR.0000145143.19711.78
  7. Barton M, Melbourne R, Morais P, Christie C. Kawasaki Syndrome associated with gruop A streptococcal and Epstein-Barr virus coinfections. Ann Trop Paediatr 2002;22:257-60. https://doi.org/10.1179/027249302125001543
  8. Konishi N, Baba K, Abe J, Maruko T, Waki K, Takeda N, et al. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr 1997;86:661-4. https://doi.org/10.1111/j.1651-2227.1997.tb08952.x
  9. Kuijpers TW, Herweijer TJ, Scholvinck L, Wertheim-Van Dillen PM, Van De Veer EM. Kawasaki disease associated with measles virus infection in a monozygotic twin. Pediatr Infect Dis J 2000;19:350-3. https://doi.org/10.1097/00006454-200004000-00018
  10. de Maddi F, Cinelli R, Rigante D, Mazzarella G, Siani P. Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome. Rheumatol Int 2009;29:1373-6. https://doi.org/10.1007/s00296-008-0830-2
  11. Uziel Y, Hashkes PJ, Kassem E, Gottesman G, Wolach B. "Unresolving pneumonia" as the main manifestation of atypical Kawasaki disease. Arch Dis Child 2003;88:940-2. https://doi.org/10.1136/adc.88.10.940
  12. Voynow JA, Schanberg L, Sporn T, Kredich D. Pulmonary complications associated with Kawasaki disease. J Pediatr 2002;140:786-7. https://doi.org/10.1067/mpd.2002.pd124772
  13. Freeman AF, Crawford SE, Finn LS, Lopez-Andreu JA, Ferrando-Monleon S, Perez-Tamarit D, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol 2003;36:102-6. https://doi.org/10.1002/ppul.10333
  14. Kobayashi Y, Koike Y, Tokutomi T, Kuroki Y, Todoroki I. Case 2: fever, rash and pulmonary involvement. diagnosis: Kawasaki disease. Acta Paediatr 2006;95:1145-8.
  15. Sengler C, Gaedicke G, Wahn U, Keitzer R. Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J 2004;23:782-4. https://doi.org/10.1097/01.inf.0000134313.86697.20
  16. Umezawa T, Saji T, Matsuo N, Odagiri K . Chest X-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol 1989;20:48-51. https://doi.org/10.1007/BF02010633
  17. Kim JY, Kwon JH, Kim KH, Yu JH, Hong YM. Chest X-ray findings and serum tumor necrosis factor-$\alpha$ levels in patients with Kawasaki disease. Korean J Pediatr 2005;48:534-8.
  18. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Japanese Ministry of Health and Welfare, 1984.
  19. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 2002;140:742-6. https://doi.org/10.1067/mpd.2002.123664
  20. Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr 2009;154:592-5. https://doi.org/10.1016/j.jpeds.2008.10.006
  21. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005;116:e760-6. https://doi.org/10.1542/peds.2005-0559
  22. Chua PK, Nerurkar VR, Yu Q, Woodward CL, Melish ME, Yanagihara R, et al. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J 2000;19:477-9. https://doi.org/10.1097/00006454-200005000-00019
  23. Talkington DF, Waites KB, Schwartz SB, Besser RE. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis and epidemiology of human Mycoplasma pneumoniae infections. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging infections 5. Washington, DC: American Society for Microbiology , 2001:57-84.
  24. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 2001;160:483-91. https://doi.org/10.1007/s004310100775
  25. Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis 1999;29:586-9. https://doi.org/10.1086/598638
  26. Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol 1997;41:895-900. https://doi.org/10.1111/j.1348-0421.1997.tb01947.x
  27. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1993;177:791-6. https://doi.org/10.1084/jem.177.3.791
  28. Cole BC. The immunobiology of mycoplasma arthritidis and its super-antigen MAM. Curr Top Microbiol Immunol 1991;174:107-19.
  29. Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken YH, editors. Manual of clinical microbiology. 7th ed. Washington, DC: American Society for Microbiology, 1999:782-94.
  30. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003;36:267-78. https://doi.org/10.1002/ppul.10346

Cited by

  1. Comorbidity of Kawasaki disease and group a streptococcal pleural effusion in a healthy child: a case report vol.6, pp.None, 2013, https://doi.org/10.2147/ijgm.s49510
  2. Hypertension Triggers the Rupture of Coronary Artery Aneurysm in an 8-Year-Old Boy With Kawasaki Disease vol.16, pp.10, 2011, https://doi.org/10.1111/jch.12394
  3. First case of redness and erosion at bacillus Calmette–Guérin inoculation site after vaccination against influenza vol.43, pp.10, 2011, https://doi.org/10.1111/1346-8138.13365
  4. Kawasaki Shock Syndrome in a 12-Year-Old Girl Mimicking Septic Shock vol.2016, pp.None, 2011, https://doi.org/10.1155/2016/4949036
  5. Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis vol.7, pp.None, 2011, https://doi.org/10.3389/fmicb.2016.00023
  6. Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience vol.62, pp.2, 2011, https://doi.org/10.1093/tropej/fmv077
  7. Kawasaki disease associated with Mycoplasma pneumoniae vol.42, pp.1, 2011, https://doi.org/10.1186/s13052-016-0292-1
  8. Kawasaki disease: etiopathogenesis and novel treatment strategies vol.13, pp.3, 2011, https://doi.org/10.1080/1744666x.2017.1232165
  9. Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study vol.6, pp.7, 2017, https://doi.org/10.1161/jaha.116.005370
  10. Advances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, vol.43, pp.1, 2011, https://doi.org/10.1186/s13052-017-0401-9
  11. Pulmonary presentation of Kawasaki disease—A diagnostic challenge vol.53, pp.1, 2018, https://doi.org/10.1002/ppul.23885
  12. Diagnosis of Kawasaki disease vol.21, pp.1, 2011, https://doi.org/10.1111/1756-185x.13224
  13. Kawasaki Disease: The Role of Immune Complexes Revisited vol.10, pp.None, 2011, https://doi.org/10.3389/fimmu.2019.01156
  14. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome vol.7, pp.None, 2019, https://doi.org/10.3389/fped.2019.00124
  15. The role of mixed Mycoplasma and Herpesvirus infections in case of skin lesions in children vol.18, pp.3, 2011, https://doi.org/10.22627/2072-8107-2019-18-3-5-10
  16. Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature vol.13, pp.1, 2011, https://doi.org/10.1186/s13256-019-2284-4
  17. Kawasaki disease shock syndrome complicated with bilateral lung consolidation in a child : A case report vol.99, pp.29, 2011, https://doi.org/10.1097/md.0000000000020998
  18. Kawasaki Hastalığında Görülen Sıra Dışı Klinik Durumlar vol.29, pp.1, 2020, https://doi.org/10.17827/aktd.532842
  19. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children vol.221, pp.None, 2020, https://doi.org/10.1016/j.clim.2020.108613
  20. Association between Mycoplasma pneumoniae Infection and Coronary Artery Aneurysm in Children with Kawasaki Disease vol.31, pp.1, 2011, https://doi.org/10.5812/ijp.104737
  21. Kawasaki disease mimickers vol.63, pp.8, 2021, https://doi.org/10.1111/ped.14561
  22. Kawasaki disease associated pulmonary involvement in infants vol.56, pp.10, 2011, https://doi.org/10.1002/ppul.25596
  23. Case of Kawasaki syndrome associated with Mycoplasma infection vol.13, pp.3, 2021, https://doi.org/10.22625/2072-6732-2021-13-3-125-130